Steven Brugger
Steven Brugger
Overview
Steve Brugger brings over 30 years of experience in the biotech and pharmaceutical industry to Affinivax. He most recently served as the Chief Executive Officer of Visterra a private biotech company based in Cambridge Mass. During his tenure at Visterra Steve led the company in closing a Series A round of financing advancing its lead antibody program toward IND and establishing strategic partnerships with both Pfizer and the Bill & Melinda Gates Foundation. Prior to Visterra Steve was the Chief Operating Officer at Momenta Pharmaceuticals. While at Momenta Steve held several leadership roles as the company grew from a private start up to a successful public traded biotechnology company.
